Pyxis Oncology, Inc. (PYXS)
2.03
+0.04
(+2.01%)
USD |
NASDAQ |
Oct 09, 16:00
2.035
0.00 (0.00%)
After-Hours: 20:00
Pyxis Oncology Price to Book Value : 11.26 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 11.26 |
| October 08, 2026 | 11.03 |
| October 07, 2026 | 11.15 |
| October 06, 2026 | 11.20 |
| October 05, 2026 | 12.42 |
| October 02, 2026 | 11.87 |
| October 01, 2026 | 12.14 |
| September 30, 2026 | 12.92 |
| September 29, 2026 | 16.08 |
| September 28, 2026 | 16.08 |
| September 25, 2026 | 15.86 |
| September 24, 2026 | 16.19 |
| September 23, 2026 | 17.86 |
| September 22, 2026 | 18.60 |
| September 21, 2026 | 17.69 |
| September 18, 2026 | 18.46 |
| September 17, 2026 | 18.91 |
| September 16, 2026 | 18.52 |
| September 15, 2026 | 18.46 |
| September 14, 2026 | 19.02 |
| September 11, 2026 | 17.80 |
| September 10, 2026 | 18.13 |
| September 09, 2026 | 18.74 |
| September 08, 2026 | 21.57 |
| September 04, 2026 | 21.57 |
| Date | Value |
|---|---|
| September 03, 2026 | 19.77 |
| September 02, 2026 | 20.79 |
| September 01, 2026 | 19.08 |
| August 31, 2026 | 17.97 |
| August 28, 2026 | 17.91 |
| August 27, 2026 | 18.41 |
| August 26, 2026 | 18.52 |
| August 25, 2026 | 16.97 |
| August 24, 2026 | 16.41 |
| August 21, 2026 | 17.08 |
| August 20, 2026 | 17.30 |
| August 19, 2026 | 18.69 |
| August 18, 2026 | 16.58 |
| August 17, 2026 | 16.75 |
| August 14, 2026 | 16.69 |
| August 13, 2026 | 16.69 |
| August 12, 2026 | 17.63 |
| August 11, 2026 | 15.69 |
| August 10, 2026 | 21.24 |
| August 07, 2026 | 20.68 |
| August 06, 2026 | 20.79 |
| August 05, 2026 | 17.36 |
| August 04, 2026 | 17.52 |
| August 03, 2026 | 16.86 |
| July 31, 2026 | 14.69 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 2.606 |
| Alnylam Pharmaceuticals, Inc. | 22.98 |
| Anika Therapeutics, Inc. | 1.909 |
| Savara, Inc. | 7.034 |
| Vericel Corp. | 5.545 |
Price to Book Value Related Metrics
| PS Ratio | 11.62 |
| Price | 2.03 |
| Earnings Yield | -69.13% |
| Market Cap | 128.77M |